These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 36314034)

  • 21. Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review.
    Belperio JA; Shaikh F; Abtin FG; Fishbein MC; Weigt SS; Saggar R; Lynch JP
    JAMA; 2022 Mar; 327(9):856-867. PubMed ID: 35230389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Refractory Sarcoidosis: A Review.
    El Jammal T; Jamilloux Y; Gerfaud-Valentin M; Valeyre D; Sève P
    Ther Clin Risk Manag; 2020; 16():323-345. PubMed ID: 32368072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of sarcoidosis].
    Londner C; Zendah I; Freynet O; Carton Z; Dion G; Nunes H; Valeyre D
    Rev Med Interne; 2011 Feb; 32(2):109-13. PubMed ID: 21156331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(27):1-66. PubMed ID: 23074532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel pharmacotherapy of sarcoidosis.
    Sah BP; Goyal S; Iannuzzi MC
    Pharmacol Ther; 2016 Jan; 157():1-9. PubMed ID: 26478443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
    Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based therapy for cutaneous sarcoidosis.
    Doherty CB; Rosen T
    Drugs; 2008; 68(10):1361-83. PubMed ID: 18578557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.
    Bonham CA; Strek ME; Patterson KC
    Curr Opin Pulm Med; 2016 Sep; 22(5):484-91. PubMed ID: 27379967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Doney L; Dressler C; Hua C; Hughes C; Naldi L; Afach S; Le Cleach L
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011535. PubMed ID: 33871055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Corticosteroids for pulmonary sarcoidosis.
    Paramothayan NS; Jones PW
    Cochrane Database Syst Rev; 2000; (4):CD001114. PubMed ID: 11034698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of renal sarcoidosis: is there a guideline? Overview of the different treatment options.
    Hilderson I; Van Laecke S; Wauters A; Donck J
    Nephrol Dial Transplant; 2014 Oct; 29(10):1841-7. PubMed ID: 24235078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sepsis Care Pathway 2019.
    Labib A
    Qatar Med J; 2019; 2019(2):4. PubMed ID: 31763206
    [No Abstract]   [Full Text] [Related]  

  • 35. Current and emerging strategies for the management of sarcoidosis.
    White ES; Lynch JP
    Expert Opin Pharmacother; 2007 Jun; 8(9):1293-311. PubMed ID: 17563264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary sarcoidosis.
    Spagnolo P; Rossi G; Trisolini R; Sverzellati N; Baughman RP; Wells AU
    Lancet Respir Med; 2018 May; 6(5):389-402. PubMed ID: 29625772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing better drugs for pulmonary sarcoidosis: determining indications for treatment and endpoints to assess therapy based on patient and clinician concerns.
    Judson MA
    F1000Res; 2019; 8():. PubMed ID: 31942239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the Clinical Evidence Supporting Repository Corticotropin Injection for FDA-Approved Indications: A Scoping Review.
    Tran KA; Harrod C; Bourdette DN; Cohen DM; Deodhar AA; Hartung DM
    JAMA Intern Med; 2022 Feb; 182(2):206-217. PubMed ID: 34902005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.